Major Depressive Disorder
|
|
0.900 |
GeneticVariation
|
GWASDB |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
GWASDB |
Genome-wide association analysis identifies 13 new risk loci for schizophrenia.
|
23974872 |
2013 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASDB |
Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample.
|
23070075 |
2013 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASDB |
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
|
18711365 |
2008 |
Attention deficit hyperactivity disorder
|
|
0.800 |
GeneticVariation
|
GWASDB |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Mental disorders
|
|
0.750 |
GeneticVariation
|
GWASDB |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Psychotic Disorders
|
|
0.730 |
GeneticVariation
|
GWASDB |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
Major Depressive Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
|
18711365 |
2008 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Genome-wide association analysis identifies 13 new risk loci for schizophrenia.
|
23974872 |
2013 |
Major Depressive Disorder
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
Attention deficit hyperactivity disorder
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Child Development Disorders, Pervasive
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Major Depressive Disorder
|
|
0.900 |
GeneticVariation
|
BEFREE |
We found that rs1006737 was associated with both schizophrenia (P(allele) = 0.0014, P(genotype) = 0.006, odds ratio (OR) = 1.384, 95% CI 1.134-1.690) and major depressive disorder (P(allele) = 0.0007, P(genotype) = 0.003, OR = 1.425, 95% CI 1.160-1.752).
|
24262814 |
2014 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
BEFREE |
This is most interesting because the common single-nucleotide polymorphism (SNP) most highly associated with BD is rs1006737, which we show here is a cis-expression quantitative trait locus for CACNA1C in human cerebellum, and the risk allele (A) is associated with decreased expression.
|
23979604 |
2014 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
BEFREE |
Recent genetic studies found the A allele of the variant rs1006737 in the alpha 1C subunit of the L-type voltage-gated calcium channel (CACNA1C) gene to be overrepresented in patients suffering from bipolar disorder, schizophrenia or major depression.
|
19781653 |
2010 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
BEFREE |
CACNA1C risk variant rs1006737 affects cortical white matter integrity in schizophrenia.
|
25470093 |
2014 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
BEFREE |
These results add to the literature suggesting that rs1006737 may be associated with schizophrenia through its detrimental effect on endophenotypic traits.
|
22957138 |
2012 |
Bipolar Disorder
|
|
0.900 |
GeneticVariation
|
BEFREE |
On the other hand, our results indicate that alterations in the functional coupling between the prefrontal cortex and the medial temporal lobe could represent a neural system phenotype that is mediated by CACNA1C rs1006737 and other genetic susceptibility loci for schizophrenia and bipolar disorder.
|
23404764 |
2014 |
Schizophrenia
|
|
0.900 |
GeneticVariation
|
BEFREE |
Our results further confirmed that rs1006737 should be categorized as an authentic risk SNP for schizophrenia in the general populations.
|
25588813 |
2015 |